158 related articles for article (PubMed ID: 11361529)
1. Fluconazole prevents yeast infections in women with HIV.
AIDS Patient Care STDS; 1996 Oct; 10(5):310. PubMed ID: 11361529
[No Abstract] [Full Text] [Related]
2. Weekly fluconazole to prevent candida.
Gilden D
GMHC Treat Issues; 1996; 10(6/7):16. PubMed ID: 11363636
[TBL] [Abstract][Full Text] [Related]
3. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Fortun Abete J
Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
[No Abstract] [Full Text] [Related]
5. Withdrawal of fluconazole suppressive therapy for thrush in patients responding to combination antiviral therapy including protease inhibitors.
Gripshover BM; Valdez H; Salata RA; Lederman MM
AIDS; 1998 Dec; 12(18):2513-4. PubMed ID: 9875599
[No Abstract] [Full Text] [Related]
6. Candidiasis at ICAAC.
Barr D; Smart T
GMHC Treat Issues; 1995 Oct; 9(10):13. PubMed ID: 11362914
[TBL] [Abstract][Full Text] [Related]
7. [Fluconazole (Diflucan): its clinical spectrum and development].
Espejo Martínez J; Alvarez Medina MP; Sánchez Morales S
Rev Clin Esp; 1997 Apr; 197 Suppl 1():86-93. PubMed ID: 9297211
[No Abstract] [Full Text] [Related]
8. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.
Hood S; Bonington A; Evans J; Denning D
AIDS; 1998 Mar; 12(4):447-8. PubMed ID: 9520182
[No Abstract] [Full Text] [Related]
9. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Blignaut E; Botes ME; Nieman HL
SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
[TBL] [Abstract][Full Text] [Related]
10. Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
Penzak SR; Gubbins PO
Am J Health Syst Pharm; 1998 Feb; 55(3):279-83. PubMed ID: 9492260
[No Abstract] [Full Text] [Related]
11. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy.
Valdez H; Gripshover BM; Salata RA; Lederman MM
AIDS; 1998 Mar; 12(5):538. PubMed ID: 9543458
[No Abstract] [Full Text] [Related]
12. [For oral candidiasis and co. Fluconazole remains in the forefront].
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():90. PubMed ID: 15373066
[No Abstract] [Full Text] [Related]
13. Geneva reports have implications for dental providers.
Ritchie J
Fac Notes (New Orleans La); 1998; 10(5):11-2. PubMed ID: 11365832
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole resistant non-albicans vaginal yeast in HIV seronegative women with vaginal discharge in Pune, India.
Kairon R; Godbole S; Kulkarni S; Ghate M; Sane S; Mehendale S; Risbud A; Shrotri A; Bharucha K
Int J Infect Dis; 2004 Jul; 8(4):251-2. PubMed ID: 15234330
[No Abstract] [Full Text] [Related]
15. Fungal infection overview.
Treat Rev; 1995 May; (no 18):10. PubMed ID: 11362589
[TBL] [Abstract][Full Text] [Related]
16. Candidiasis in immune-compromised women.
Cadman J
GMHC Treat Issues; 1997; 11(7-8):18. PubMed ID: 11364644
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)].
Pekhlivanov B; Amaliev I; Ivancheva Kh; Zisova L
Akush Ginekol (Sofiia); 2005; 44 Suppl 2():25-7. PubMed ID: 16028400
[TBL] [Abstract][Full Text] [Related]
18. Oral fluconazole and vulvovaginal candidiasis: prevention is not always better than cure.
Prescrire Int; 2013 Sep; 22(141):205. PubMed ID: 24171211
[TBL] [Abstract][Full Text] [Related]
19. Oral candidiasis in HIV-infected patients.
Brawner DL; Hovan AJ
Curr Top Med Mycol; 1995; 6():113-25. PubMed ID: 8724244
[No Abstract] [Full Text] [Related]
20. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
Vazquez JA; Peng G; Sobel JD; Steele-Moore L; Schuman P; Holloway W; Neaton JD
Clin Infect Dis; 2001 Oct; 33(7):1069-75. PubMed ID: 11528582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
